Work

Dual targeting of VEGF and PD-1: A phase I/II trial of ivonescimab, a novel bispecific antibody, in recurrent glioblastoma.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps2101

Authors: Anuj Dilip Patel, Ashley Aaroe, Carlos Kamiya-Matsuoka, Ruitao Lin, Nazanin Majd, Barbara Jane O'Brien, Chirag B. Patel, Shiao-Pei S. Weathers, Vinay K. Puduvalli

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410818462

FWCI: 0.534

Cites:

Cited by: 1

Related to: 10